文献速递腹部技术与安全CT

基于CT影像组学的结直肠癌肝转移患者生存分析:一项全面的机器学习基准研究

A Comprehensive Machine Learning Benchmark Study for Radiomics-Based Survival Analysis of CT Imaging Data in Patients With Hepatic Metastases of CRC.
PubMed 文献 · Invest Radiol · 2023-07-28

本研究基于既往前瞻性随机试验中491例结直肠癌肝转移患者的门静脉期CT数据,构建了包含预处理、特征选择、降维、超参数优化和模型训练的机器学习基准流程,评估60种流程变体对总生存的预测。线性混合模型显示随机生存森林流程表现相似或优于其他算法,但影像组学特征未提供超出临床参数的额外预后价值。

要点

  • 在491例结直肠癌肝转移患者中评估60种机器学习流程变体预测总生存。
  • 随机生存森林流程表现 consistently 相似或优于glmnet和xgboost。
  • 影像组学特征未观察到超出临床参数的额外预后价值。

核心结论

  • 影像组学特征捕捉患者临床情况的能力与临床参数相当,但未观察到这些特征带来相关的额外预后价值。

诊断标准与关键数值

  • 评估3种机器学习算法(glmnet、随机生存森林、xgboost)在5种临床数据、肿瘤影像组学与全肝特征组合下的表现,以集成Brier分数为性能指标,通过嵌套交叉验证优化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Optimizing a machine learning (ML) pipeline for radiomics analysis involves numerous choices in data set composition, preprocessing, and model selection. Objective identification of the optimal setup is complicated by correlated features, interdependency structures, and a multitude of available ML algorithms. Therefore, we present a radiomics-based benchmarking framework to optimize a comprehensive ML pipeline for the prediction of overall survival. This study is conducted on an image set of patients with hepatic metastases of colorectal cancer, for which radiomics features of the whole liver and of metastases from computed tomography images were calculated. A mixed model approach was used to find the optimal pipeline configuration and to identify the added prognostic value of radiomics features.

MATERIALS AND METHODS: In this study, a large-scale ML benchmark pipeline consisting of preprocessing, feature selection, dimensionality reduction, hyperparameter optimization, and training of different models was developed for radiomics-based survival analysis. Portal-venous computed tomography imaging data from a previous prospective randomized trial evaluating radioembolization of liver metastases of colorectal cancer were quantitatively accessible through a radiomics approach. One thousand two hundred eighteen radiomics features of hepatic metastases and the whole liver were calculated, and 19 clinical parameters (age, sex, laboratory values, and treatment) were available for each patient. Three ML algorithms-a regression model with elastic net regularization (glmnet), a random survival forest (RSF), and a gradient tree-boosting technique (xgboost)-were evaluated for 5 combinations of clinical data, tumor radiomics, and whole-liver features. Hyperparameter optimization and model evaluation were optimized toward the performance metric integrated Brier score via nested cross-validation. To address dependency structures in the benchmark setup, a mixed-model approach was developed to compare ML and data configurations and to identify the best-performing model.

RESULTS: Within our radiomics-based benchmark experiment, 60 ML pipeline variations were evaluated on clinical data and radiomics features from 491 patients. Descriptive analysis of the benchmark results showed a preference for RSF-based pipelines, especially for the combination of clinical data with radiomics features. This observation was supported by the quantitative analysis via a linear mixed model approach, computed to differentiate the effect of data sets and pipeline configurations on the resulting performance. This revealed the RSF pipelines to consistently perform similar or better than glmnet and xgboost. Further, for the RSF, there was no significantly better-performing pipeline composition regarding the sort of preprocessing or hyperparameter optimization.

CONCLUSIONS: Our study introduces a benchmark framework for radiomics-based survival analysis, aimed at identifying the optimal settings with respect to different radiomics data sources and various ML pipeline variations, including preprocessing techniques and learning algorithms. A suitable analysis tool for the benchmark results is provided via a mixed model approach, which showed for our study on patients with intrahepatic liver metastases, that radiomics features captured the patients' clinical situation in a manner comparable to the provided information solely from clinical parameters. However, we did not observe a relevant additional prognostic value obtained by these radiomics features.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Stüber AT, Coors S, Schachtner B, et al. A Comprehensive Machine Learning Benchmark Study for Radiomics-Based Survival Analysis of CT Imaging Data in Patients With Hepatic Metastases of CRC. Invest Radiol. 2023. PMID: 37504498. doi:10.1097/RLI.0000000000001009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。